INCORRECT
Thomsen myotonia congenita is a chloride channelopathy, which manifests in similar ways to Becker myotonia congenita. However, symptoms of Thomsen myotonia congenita tend to start in early childhood or infancy, while Becker myotonia congenita typically manifests between 4 and 12 years of age. Thomsen myotonia is an autosomal dominant disease and the parents of this patient had no history of myotonia.
CORRECT
Becker myotonia congenita is a chloride channelopathy, which predominantly affects the legs. Becker myotonia congenita is an autosomal recessive disease, with onset of symptoms typically occurring between 4 and 12 years of age.
Paramyotonia congenita is an autosomal dominant sodium channelopathy. This patient expresses heterozygous mutations in the ClCN1 gene, with no family history of myotonia, which indicates an autosomal recessive chloride channelopathy.
Myotonia fluctuans is an autosomal dominant sodium channelopathy. Myotonia fluctuans symptoms tend to fluctuate from day to day and are associated with a lack of or variable cold sensitivity. This patient expresses heterozygous mutations in the ClCN1 gene, with no family history of myotonia, which indicates an autosomal recessive chloride channelopathy.
Myotonia permanens is an autosomal dominant sodium channelopathy. Myotonia permanens is associated with constant, generalised myotonia that can affect the thorax, and consequently, swallowing and breathing. This patient expresses heterozygous mutations in the ClCN1 gene, with no family history of myotonia, which indicates an autosomal recessive chloride channelopathy.
Hyperkalemic periodic paralysis is an autosomal dominant sodium channelopathy. Myotonia is generally mild and can be accompanied by episodic weakness. Triggers of hyperkalemic periodic paralysis myotonia include dietary potassium. This patient expresses heterozygous mutations in the ClCN1 gene, with no family history of myotonia, which indicates an autosomal recessive chloride channelopathy.